Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Cerus Corp Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $3.24 Million - $4.53 Million	-625,016 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $2.23 Million - $3.59 Million	625,016 New	625,016 $3.43 Million

Others Institutions Holding CERS

# of Institutions

156

Shares Held

147M

Call Options Held

84.2K

Put Options Held

55.5K

Baker Bros. Advisors LP New York, NY

19.5M
Shares

$36.4 Million
0.36% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

18.2M
Shares

$34.1 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.9M
Shares

$26 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.8M
Shares

$20.3 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

8.54M
Shares

$16 Million
0.01% of portfolio

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account